Skip to main content
. 2011 Feb 17;21(9):2177–2186. doi: 10.1093/cercor/bhr006

Figure 2.

Figure 2.

Fezf2 regulates the A–P patterning of the forebrain. (A) Differences in the expression levels of Fezf2 and other patterning markers at day 6 between control and Dox-treated groups. (B) qPCR indicating the changes in the expression of Fezf2 and rostrocaudal genes at different time points after being treated with Dox during days 4–6. (C) Analysis of the expression of the rostrocaudal genes at day 10 showed that there was an increase in the expression of Foxg1 and Six3 and a decrease in En1 expression when Dox was added and that these changes were time dependent. Data are presented as Mean ± SD. *P < 0.05 versus Control (No Dox) group, n = 3.